Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EENCD: EEN + Corticosteroids in Crohn's Disease
NCT03833596Phase 4Terminated
- Sponsor
- McMaster University
- Start
- Oct 2018
- Primary completion
- Nov 2019
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (3 arms), sponsored by McMaster University. Primary endpoint: Clinical Remission (Crohn's Disease Activity Index < 150) at 6 weeks. Started Oct 2018; status: terminated.
Beyond the preview
Go deeper on NCT03833596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03833596.